Comparison of radiation dose exposure in patients undergoing percutaneous coronary intervention vs. peripheral intervention

被引:3
|
作者
Arif, Salech [1 ]
Bartus, Stanislaw [1 ]
Rakowski, Tomasz [1 ]
Bobrowska, Beata [1 ]
Rutka, Joanna [2 ]
Zabowka, Anna [2 ]
Tokarek, Tomasz [2 ]
Dudek, Dariusz [1 ]
Dubiel, Jacek [1 ]
机构
[1] Jagiellonian Univ, Coll Med, Univ Hosp, Dept Cardiol 2, PL-31501 Krakow, Poland
[2] Jagiellonian Univ, Coll Med, PL-31501 Krakow, Poland
来源
POSTEPY W KARDIOLOGII INTERWENCYJNEJ | 2014年 / 10卷 / 04期
关键词
radiation dose exposure; fluoroscopy time; peripheral intervention; percutaneous transluminal angioplasty; percutaneous coronary intervention; ANGIOPLASTY; CATHETERIZATION; COMPLEXITY; INJURY; TIME;
D O I
10.5114/pwki.2014.46776
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Most endovascular techniques are associated with patient and personal exposure to radiation during the procedure. Ionising radiation can cause deterministic effects, such as skin injury, as well as stochastic effects, which increase the long-term risk of malignancy. Endovascular operators need to be aware of radiation danger and take all necessary steps to minimise the risk to patients and staff. Some procedures, especially percutaneous peripheral artery revascularisation, are associated with increased radiation dose due to time-consuming operations. There is limited data comparing radiation dose during percutaneous coronary intervention (PCI) with percutaneous transluminal angioplasty (PTA) of peripheral arteries. Aim: To compare the radiation dose in percutaneous coronary vs. peripheral interventions in one centre with a uniform system of protection methods. Material and methods: A total of 352 patients were included in the study. This included 217 patients undergoing PCI (single and multiple stenting) and 135 patients undergoing PTA (in lower extremities, carotid artery, renal artery, and subclavian artery). Radiation dose, fluoroscopy time, and total procedural time were reviewed. Cumulative radiation dose was measured in gray (Gy) units. Results: The total procedural time was significantly higher in PTA (PCI vs. PTA: 60 (45-85) min vs. 75 (50-100) min), p < 0.001. The radiation dose for PCI procedures was significantly higher in comparison to PTA (PCI vs. PTA: 1.36 (0.83-2.23) Gy vs. 0.27 (0.13 - 0.46) Gy), p < 0.001. There was no significant difference in the fluoroscopy time (PCI vs. PTA: 12.9 (8.2-21.5) min vs. 14.4 (8.0-22.6) min), p = 0.6. The analysis of correlation between radiation dose and fluoroscopy time in PCI and PTA interventions separately shows a strong correlation in PCI group (r = 0.785). However, a weak correlation was found in PTA group (r = 0.317). Conclusions: The radiation dose was significantly higher during PCI in comparison to PTA procedures despite comparable fluoroscopy time and longer total procedure time in PTA. Fluoroscopy time is a reliable parameter to control the radiation dose exposure in coronary procedures. The increasing complexity of endovascular interventions has resulted in the increase of radiation dose exposure during PCI procedures.
引用
收藏
页码:308 / 313
页数:6
相关论文
共 50 条
  • [41] Quality of Life in Patients Undergoing Percutaneous Coronary Intervention
    Tsoulou, Vasiliki
    Vasilopoulos, Georgios
    Kapadochos, Theodore
    Pavlatou, Niki
    Kalogianni, Antonia
    Toulia, Georgia
    Dousis, Evangellos
    Panoutsopoulos, George
    Kourakos, Michael
    Polikandrioti, Maria
    CLINICS AND PRACTICE, 2023, 13 (03) : 621 - 637
  • [42] Bleeding in patients Undergoing Percutaneous Coronary Intervention (PCI)
    Wajih-ur-Rehman
    Hameed, Shahid
    Naveed, Tahir
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2011, 27 (05) : 958 - 962
  • [43] The role of eptifibatide in patients undergoing percutaneous coronary intervention
    Zeymer, Uwe
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (08) : 1147 - 1154
  • [44] Antithrombotic therapy in patients undergoing percutaneous coronary intervention
    Popma, JJ
    Ohman, EM
    Weitz, J
    Lincoff, M
    Harrington, RA
    Berger, P
    CHEST, 2001, 119 (01) : 321S - 336S
  • [45] Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention
    Galli, Mattia
    Laborante, Renzo
    Andreotti, Felicita
    Vergallo, Rocco
    Montone, Rocco Antonio
    Iaconelli, Antonio
    Trani, Carlo
    Burzotta, Francesco
    Crea, Filippo
    D'Amario, Domenico
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (08)
  • [46] IS THERE NEPHROPROTECTION FOR PATIENTS ON STATINS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION?
    Ivanova, V.
    Spotti, J.
    Vido, D. A.
    Lasorda, D. M.
    Biederman, R. W.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 112 - 112
  • [47] Enoxaparin for anticoagulation in patients undergoing percutaneous coronary intervention
    James, Stefan
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [49] Percutaneous coronary intervention vs. medical therapy in patients on dialysis with coronary artery disease in China
    Xie Enmin
    Wu Yaxin
    Ye Zixiang
    He Yong
    Zeng Hesong
    Luo Jianfang
    Chen Mulei
    Pang Wenyue
    Xu Yanmin
    Gao Chuanyu
    Guo Xiaogang
    Cai Lin
    Ji Qingwei
    Yang Yining
    Wu Di
    Yuan Yiqiang
    Wan Jing
    Ma Yuliang
    Zhang Jun
    Du Zhimin
    Yang Qing
    Cheng Jinsong
    Ding Chunhua
    Ma Xiang
    Yin Chunlin
    Fan Zeyuan
    Tang Qiang
    Li Yue
    Sun Lihua
    Lu Chengzhi
    Chi Jufang
    Yao Zhuhua
    Gao Yanxiang
    Yu Changan
    Ren Jingyi
    Zheng Jingang
    中华医学杂志英文版, 2025, 138 (03)
  • [50] High dose statins should be used in all patients undergoing percutaneous coronary intervention
    Sardella, Gennaro
    Lucisano, Luigi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (01) : E139 - E139